NADDI Releases Second Quarter 2016 Statistics for NPLEx System

Real-time, stop-sale technology continues to be a vital resource for pharmacists and law enforcement in the fight against criminal activity


LUTHERVILLE , Md., Aug. 8, 2016 (GLOBE NEWSWIRE) -- The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of diversion of medicines for illegal purposes – praised recent results from the National Precursor Log Exchange (NPLEx) during the second quarter of this calendar year. From April 1, 2016, to June 30, 2016, NPLEx successfully blocked the illegal sale of 789,192 boxes of medicine containing pseudoephedrine (PSE), which can be diverted by criminals to make meth. As a result, NPLEx kept 2,059,299 grams of PSE out of the hands of potential criminals.

The NPLEx system, adopted by 33 states across the country, aids law enforcement professionals by blocking unlawful purchases of medicine containing pseudoephedrine (PSE) at the pharmacy counter. Additionally, NPLEx provides law enforcement officers and narcotics agents with valuable information such as "watch lists" that notify them via email when a meth suspect attempts to purchase PSE. This information can then be subpoenaed by prosecutors as they build cases and put drug criminals behind bars.
Over 44,000 retailers nationwide report PSE sales to NPLEx, and some states have also supplemented NPLEx by using the technology to ban the sale of any PSE products to those previously convicted of a meth crime. In Alabama, Oklahoma and Tennessee similar legislation was passed in 2012, 2013 and 2014, respectively, and these states experienced significant declines in meth lab seizures – 77 percent decline in Alabama, 88 percent in Oklahoma and 69 percent in Tennessee.
"As we reach the halfway mark of 2016, NPLEx continues to produce results," said NADDI Executive Director Charles Cichon. "With Georgia adopting NPLEx earlier this year, now 33 states across the country are working together, utilizing the system and curbing criminal meth activity. Legislators, law enforcement and retailers should be commended for keeping pseudoephedrine out of the hands of criminals without punishing law-abiding cold and allergy sufferers."
About NADDI and Public Safety
Established in 1989, the National Association of Drug Diversion Investigators, Inc. (NADDI) is a unique membership organization whose members are responsible for investigating and prosecuting pharmaceutical drug diversion. The organization has proven to be a valuable asset to law enforcement, the pharmaceutical industry and health regulatory personnel. NADDI's objective is simple: to improve the members' ability to investigate, and prosecute, pharmaceutical drug diversion. You can learn about NADDI here:


Contact Data